Serine Active Site Containing 1 (SERAC1) (N-Term) Peptide
SERAC1
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all SERAC1 products
- SERAC1 (Serine Active Site Containing 1 (SERAC1))
- Protein Region
- N-Term
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- KTLIGLARSE ESDLRFFLLP PPLPSLKEDS STEEELRQLL ASLPQTELDE
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-SERAC1 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- SERAC1 (Serine Active Site Containing 1 (SERAC1))
- Synonyms
- 4930511N22Rik Peptide, D17Ertd141e Peptide, serine active site containing 1 Peptide, SERAC1 Peptide, Serac1 Peptide
- Background
-
The function of this protein remains unknown.
Alias Symbols: FLJ14917, FLJ30544
Protein Size: 654 - Molecular Weight
- 74 kDa
- Gene ID
- 84947
- NCBI Accession
- NM_032861, NP_116250
- UniProt
- Q96JX3
-
You are here:
